尽管净亏损 2.65 亿美元，沃尔格林博姿联盟 (WBA) 股价仍飙升 23%

沃尔格林博姿联盟公司（纳斯达克股票代码：WBA）尽管报告最近一个季度净亏损 2.65 亿美元（每股 31 美分），但仍激发了投资者的乐观情绪。

Walgreens Boots Alliance Inc. (Nasdaq: WBA) stock soared 23.43% to $11.38 per share on January 10 after the company reported a net loss of $265 million (31 cents per share) for the most recent quarter, beating analyst expectations despite the loss.

沃尔格林博姿联盟公司（纳斯达克股票代码：WBA）1月10日股价飙升23.43%，至每股11.38美元，此前该公司报告最近一个季度净亏损2.65亿美元（每股31美分），尽管亏损，但仍超出了分析师的预期。

The company, which is grappling with the challenges of fiscal 2024, appears to be on the road to recovery, focusing on restructuring and trimming its footprint to regain profitability.

该公司正在努力应对 2024 财年的挑战，似乎正在走上复苏之路，重点关注重组和削减业务规模，以恢复盈利能力。

Shares of Walgreens soared following the earnings report, signaling that investors are optimistic about the company’s strategic moves for fiscal 2025 and beyond.

沃尔格林的股价在财报发布后飙升，表明投资者对该公司 2025 财年及以后的战略举措持乐观态度。

One of the key pillars of Walgreens’ recovery plan is its aggressive store closure strategy. The company announced it is closing 1,200 underperforming stores, with 500 slated to be closed in fiscal 2025.

沃尔格林复苏计划的关键支柱之一是其积极的门店关闭策略。该公司宣布将关闭 1,200 家业绩不佳的门店，其中 500 家计划在 2025 财年关闭。

These moves are part of a broader initiative to optimize its retail pharmacy operations, reduce costs, and improve cash flow. The company emphasized that its restructuring efforts, though costly, are essential for stabilizing its business and positioning it for long-term success.

这些举措是优化零售药房运营、降低成本和改善现金流的更广泛计划的一部分。该公司强调，重组工作虽然成本高昂，但对于稳定其业务并为其取得长期成功至关重要。

“We are taking bold actions to stabilize our Retail Pharmacy by improving operating costs, enhancing cash flow, and addressing reimbursement models, which have impacted our financial results,” said Tim Wentworth, CEO of Walgreens Boots Alliance, in a press release.

沃尔格林博姿联盟首席执行官蒂姆·温特沃斯在一份新闻稿中表示：“我们正在采取大胆行动，通过降低运营成本、增强现金流和解决影响我们财务业绩的报销模式来稳定我们的零售药房。”

“We believe in a sustainable, retail pharmacy-led operating model, and these actions will support our company’s long-term success and value creation for our stakeholders.”

“我们相信以零售药店为主导的可持续运营模式，这些行动将支持我们公司的长期成功并为利益相关者创造价值。”

While Walgreens is facing challenges, the company has seen growth in several key business areas.

尽管沃尔格林面临挑战，但该公司在几个关键业务领域取得了增长。

The retail pharmacy division saw $30.87 billion in quarterly sales, up 6.6% year-over-year. Similarly, Walgreens’ health care division reported $2.17 billion in revenue, marking a 12% increase from the previous year.

零售药品部门季度销售额为308.7亿美元，同比增长6.6%。同样，沃尔格林医疗保健部门的收入为 21.7 亿美元，比上年增长 12%。

The company’s international unit also saw a healthy uptick in sales, reaching $6.43 billion, a 10.2% increase year-over-year.

该公司的国际部门销售额也出现健康增长，达到 64.3 亿美元，同比增长 10.2%。

These positive results in multiple sectors provide hope that the company’s focus on healthcare, coupled with its ongoing restructuring efforts, could allow it to weather the storm of its recent losses.

多个行业的这些积极成果为该公司对医疗保健的关注以及持续的重组努力带来了希望，可以使其渡过近期亏损的风暴。

Amid these developments, there has also been speculation that Walgreens may be in talks to sell itself to private equity firm Sycamore Partners.

在这些事态发展中，还有人猜测沃尔格林可能正在就将自己出售给私募股权公司 Sycamore Partners 进行谈判。

While nothing concrete has emerged, the discussions have fueled further interest in Walgreens’ stock.

虽然没有出现任何具体消息，但讨论进一步激发了人们对沃尔格林股票的兴趣。

The company’s restructuring, coupled with its healthy growth in multiple sectors, has likely made it an attractive acquisition target for investors looking to capitalize on its turnaround potential.

该公司的重组，加上其在多个领域的健康增长，可能使其成为寻求利用其扭亏为盈潜力的投资者的有吸引力的收购目标。

Despite a significant loss this quarter, Walgreens is setting itself up for a more stable future.

尽管本季度出现重大亏损，沃尔格林仍在为更加稳定的未来做好准备。

The stock surge following its earnings beat suggests investor confidence is high in the company’s ability to recover.

盈利超出预期后股价飙升，表明投资者对该公司的复苏能力充满信心。

With its ongoing restructuring efforts, growth in health care and retail pharmacy, and possible acquisition talks, Walgreens is actively working toward regaining its footing in a challenging market environment.

通过持续的重组努力、医疗保健和零售药房的增长以及可能的收购谈判，沃尔格林正在积极努力在充满挑战的市场环境中重新站稳脚跟。

The company’s continued efforts to stabilize its operations while pursuing growth in its key business segments could pave the way for a promising year ahead.

该公司继续努力稳定运营，同时追求关键业务领域的增长，这可能为未来充满希望的一年铺平道路。